Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline's new asthma drug gets a split vote from FDA advisers
GlaxoSmithKline's new asthma drug gets a split vote from FDA advisers
GlaxoSmithKline's new asthma drug gets a split vote from FDA advisers
Submitted by
admin
on June 12, 2015 - 10:50am
Source:
Fierce Biotech
News Tags:
GSK
asthma
advisory panels
FDA
mepolizumab
Headline:
GlaxoSmithKline's new asthma drug gets a split vote from FDA advisers
Do Not Allow Advertisers to Use My Personal information
